At the cutting edge of medical technology
The WATCHMAN device, used at The Valley Hospital, functions as a filter to seal the opening to the left atrial appendage (LAA) of the heart. It prevents blood clots that form in the AGA from breaking off and going to the brain.
New Jersey hospitals use the latest medical device technology to treat patients.
By Anthony Vecchione, Contributing Writer on June 7, 2022
Medical technology has changed the face of healthcare. Wearable heart to surgical robots, new technologies have helped physicians reduce morbidity and mortality and improve patients’ quality of life.
Here’s a look at three New Jersey health systems that have successfully deployed breakthrough drugstechnology.
In 2021, the global surgical robot market was valued at $3.6 billion. According to San Francisco-based Grandview Research, it is expected to grow at an annual growth rate of 19.3% from 2022 to 2030. A shortage of doctors and surgeons and Growing adoption of automated instruments used for surgeries is among the major factors driving the market.
At Saint-Pierre University Hospital in New Brunswick, the robotics program has gained ground over the past decade.
“Our robotic usWe are in the upper 90 percentiles compared to the rest of the country,” says David A. Laskow, MD, director of the department of surgery.
Laskow adds that almost all general surgeons have significant experience using the DaVinci robot currently being implemented.ed for liver resection, distal pancreatomy and robotic splenectomy, and all gastric sleeves for bariatric surgery.
One of the biggest costs to the hospital is length of stay, according to Laskow.
“Because we are able to do these robotic procedures if effEffectively and efficiently, the length of stay between an open case (traditional surgery) and robotic surgery is radically different. As the length of stay decreases, you will recoup the costs,” says Laskow.
New technologies are also used in St. Peter’s to help doctors fight sleep apnea and fecal and urinary incontinence.
InterStim technology, from Medtronic, delivers electrical stimulation to the sacral nerves in the pelvic region, restoring communication between the brain and gut and ultimately reducing symptoms.who.
As an alternative to traditional CPAP (continuous positive airway pressure therapy) for patients with sleep apnea, St. Peter’s physicians deployed an implantable upper airway stimulation device from Inspire Medical Systems, Inc. device sstabilizes a patient’s airway while they sleep to prevent obstruction.
According to the Centers for Disease Control and Prevention, lung cancer is the leading cause of cancer death and the second most diagnosed cancer among men and women in the United States.
Traditionally, patients with spots on their lungs had to undergo a procedure called a needle biopsy in which a radiologist stuck a needle through the chest wall and into the lungs to obtain a sample of tissue for the biopsy.
Charles Shieh, MD, a chest thruston, and medical director of lung cancer at Inspira Health, says many of the spots are in places that don’t lend themselves to needle biopsy.
At Inspira Health, physicians use the Redwood City, California-based Monarch bronchoscopy platform in Auris Health, Inc., since 2021.
Shieh says navigational robotic bronchoscopy allows doctors to get a biopsy from the inside out through the airways rather than the outside in through the skin.
“He looks at your airways or trachea and in smaller respiratory tracts. Traditional bronchoscopy is unguided, meaning the doctor does not know where it is in the lung. However, with a navigational bronchoscopy using the Monarch platform, when you perform the procedure, you know exactly where you are in the chest..”
Additionally, Shieh says the technology allows the surgeon to both diagnose and follow through on any necessary treatment, such as resection (surgical removal).
“You can think of this technology as a one-stop-shop. If the patient arrives with a lung cancer, I will be able to diagnose the patient as well as treat them,” he says.
Another benefit, Shieh says, is that patients don’t have to travel to a huge medical center to benefit from the technology: “They can go to their local hospital here in South Jersey at Inspira, and we are able to perform all of these functions that only larger centers could previously perform.
Cardiologists at Ridgewood Valley Hospital have a new tool in their arsenal to treat atrial fibrillation (Afib), one of the mmost common heart conditions.
“There has been great interest in identifying high-risk patients with Afib and providing them with treatment options that will reduce their likelihood of stroke,” says Suneet Mittal, MD, director, electrophysiology, associate chief of cardiology, medical director of the Snyder AF Center, director of cardiac research at Valley Hospital.
Mittal points out that while blood thinners are commonly used to prevent blood clots from forming in the heart, they can lead to bleeding when used. for a long period of time.
He added that one of the main reasons people develop strokes with Afib is that they develop a blood clot in their heart which can break off and travel to the brain and lodge there and cause a stroke. cerebrovascular.
As an alternative to blooddiluents for Afib patients at high risk of bleeding, Mittal and his colleagues turned to Boston Scientific’s WATCHMAN device and Abbott’s Amplatzer Amulet.
“The Watchman and Amulet devices work on the principle basically placing a filter to seal off the opening of the left atrial appendage (LAA),” explains Mittal. “These devices prevent blood clots that form in the LAA from breaking off and going to the brain and causing a stroke.”
Mittal says studies show that if these devices can be successfully implanted in patients, so the risk of stroke is much lower than would be expected if they had not been on blood thinners.
Implantable devices usually involve an upfront cost, compared to blood thinners wheree there is a daily cost for a long time, according to Mittal.
“The biggest cost is the risk of morbidity. If you leave someone disabled due to a stroke, it can cause a lot of direct and indirect costs to our society.
Mittal says it’s impossibleIt is important to educate patients who have Afib that they have treatment options.
“Blood thinners will work for the vast majority of the patients. For those having trouble with a blood thinner, they should know that more options are available.
For more business news, visit NYC News Now.